HB 3613 — Creates the Office of Pharmaceutical Purchasing within the Oregon Department of Administrative Services to support multiagency and multistate collaborative purchasing of pharmaceuticals, drive down the cost of prescription drugs for residents of this state and manage the Oregon Prescription Drug Program.
Last action — In House Committee
-
✓Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill is in committee in the House. Introduced February 20, 2025. It must pass committee before a floor vote.
Next likely step: a committee vote, then a floor vote in the House.
Odds of enactment
Low chanceBased on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
In Committee
Current position in the legislative process.
-
1 sponsor
1 primary, 0 co-sponsors signed on.
-
Single-party support
Sponsorship is currently within one party (1 D).
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
Summary
Digest: Creates the OPP and moves the OPDP to OPP. Makes some changes to OPDP and PMPDP. Takes effect 91 days after session ends. (Flesch Readability Score: 88.4). Creates the Office of Pharmaceutical Purchasing within the Oregon Department of Administrative Services to support multiagency and multistate collaborative purchasing of pharmaceuticals, drive down the cost of prescription drugs for residents of this state and manage the Oregon Prescription Drug Program. Creates an advisory board within the Office of Pharmaceutical Purchasing to assist in coordinating pharmaceutical purchasing across state agencies and programs. Transfers the Oregon Prescription Drug Program from the Oregon Health Authority to the Office of Pharmaceutical Purchasing and modifies the program, including by requiring certain agencies and coordinated care organizations to participate. Clarifies that a uniform Practitioner-Managed Prescription Drug Plan and preferred drug list should be used in both fee-for-service reimbursements and prescription drugs provided by coordinated care organizations. Takes effect on the 91st day following adjournment sine die.
Bill Text
We don't have the full text on file for this bill yet.
Read HB 3613 on the official Oregon source →Action History
-
In House Committee
Sponsors
- Travis Nelson · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 89 not signed on
Sponsors (1)
- Travis Nelson Democrat
Co-sponsors (0)
None.
Not signed on (89)
89 members have not signed on to this bill.
Show all 89 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HB 3613 do?
- Digest: Creates the OPP and moves the OPDP to OPP. Makes some changes to OPDP and PMPDP. Takes effect 91 days after session ends. (Flesch Readability Score: 88.4). Creates the Office of Pharmaceutical Purchasing within the Oregon Department of Administrative Services to support multiagency and multistate collaborative purchasing of pharmaceuticals, drive down the cost of prescription drugs for residents of this state and manage the Oregon Prescription Drug Program. Creates an advisory board within the Office of Pharmaceutical Purchasing to assist in coordinating pharmaceutical purchasing across state agencies and programs. Transfers the Oregon Prescription Drug Program from the Oregon Health Authority to the Office of Pharmaceutical Purchasing and modifies the program, including by requiring certain agencies and coordinated care organizations to participate. Clarifies that a uniform Practitioner-Managed Prescription Drug Plan and preferred drug list should be used in both fee-for-service reimbursements and prescription drugs provided by coordinated care organizations. Takes effect on the 91st day following adjournment sine die.
- Who sponsors HB 3613?
- HB 3613 is sponsored by Travis Nelson (Democrat).
- What is the current status of HB 3613?
- This bill is in committee in the House. Introduced February 20, 2025. It must pass committee before a floor vote.
- Where can I track HB 3613?
- Track HB 3613 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 3613
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 3613
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →